BridgeMD
Compares treatment options for Crohn Disease (CD)
Official title Hybrid Endoscopic Stricturotomy Plus Balloon Dilation Versus Stricturotomy Alone for Short Crohn's Disease Strictures
ClinicalTrials.gov ID: NCT06958159
What this study is testing
- What it's testing
- Crohn's disease is a chronic condition that can lead to inflammation and narrowing (strictures) of the intestine, causing symptoms like pain, bloating, and difficulty with bowel movements. These strictures are often treated with endoscopic procedures such as balloon dilation or stricturotomy to widen the narrowed segments and relieve symptoms.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Adults aged 18 to 65 years.
- Diagnosed Crohn's disease based on clinical, endoscopic, histologic, or radiologic criteria.
- Presence of fibrotic or mixed strictures measuring less than 3 cm in length.
- A maximum of two strictures per patient.
- Strictures located in endoscopically accessible sites
You likely can't join if
- Predominantly ulcerated or active inflammatory strictures.
- Strictures longer than 3 cm.
- Strictures not accessible via standard colonoscopy.
- Pregnancy.
- Three or more strictures identified in a single patient.
- Prior endoscopic stricturotomy at the same stricture site.
The study team makes the final eligibility decision.
Where it's taking place
- Hyderabad, Telangana, India
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Hyderabad, Telangana, India. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.